Language switcher

This page has not been translated yet

The pros and cons of genome editing

All over the world, scientists are discussing the opportunities and risks of genome editing. Plant geneticists want to breed resilient, high-yield plants to combat famine. Critics warn against the unpredictable impact on human health and the environment. Medical experts want to cure hereditary diseases and treat cancer while ethicists fear that this could lead to “designer humans”.

Genome editing in crops

All over the world, scientists are discussing the opportunities and risks of genome editing. Plant geneticists want to breed resilient, high-yield plants to combat famine. Critics warn against the unpredictable impact on human health and the environment. Medical experts want to cure hereditary diseases and treat cancer while ethicists fear that this could lead to “designer humans”.

Genome editing in humans

Medics hope that they will be able to cure monogenic hereditary diseases such as Huntington’s disease, muscular dystrophy and cystic fibrosis. Interventions into the immune system also make it possible to treat acquired diseases such as cancer and AIDS. But many ethical issues have not yet been resolved. What impact do the changes have on the interaction of the genes? And how can we prevent unwanted, “off-target” effects that may, for example, modify genes that were not supposed to be modified and could cause cancer?

Audioplayer

Martin Lohse about precision (German)

Pharmacologist

0:00 / 0:00

Audioplayer

Jörg Vogel on the concerns (German)

Molecular Biologist

0:00 / 0:00

Changes to the germ-line

In medical applications, a basic differentiation has to be made between modifications to body cells and modifications to germ-line cells such as egg and sperm cells. Changes to the germ-line are inherited to the next generations. In Germany, as in several other European countries, interventions to the germ-line are prohibited. The US and United Kingdom are considering exemptions in the case of monogenic hereditary disorders. However, the long-term effects of this type of germ-line treatment cannot be foreseen. Ethicists are concerned that if genetic defects can be corrected at the embryonic stage, other traits could also be transferred into the genome, such as higher intelligence or stronger muscles. How far away are we then from “designer humans”?

Audioplayer

Ingrid Schneider warns of premature steps (German)

Political scientist

0:00 / 0:00

Research and responsibility

In spite of all the unanswered questions, the German academies and the German Research Foundation (DFG) believe that Germany should participate in research in this field and work towards the responsible application of the techniques involved. Regarding human germ-line modifications, however, that can be inherited to the next generation, the academies and the DFG are in favour of an international moratorium, as are numerous international researchers. On the contrary, chinese scientists supposedly already changed the genome of human embryos, making use of CRISPR/Cas9. The German science academies call for a societal debate: Before mankind starts rewriting its own DNA through germ-line interventions, the open issues need to be discussed and the associated benefits and potential risks evaluated by the scientific community and society as a whole.

Audioplayer

Jörg Hacker about the current international state (German)

Microbiologist

0:00 / 0:00

Audioplayer

Jochen Taupitz asks ethical questions (German)

Medical ethicist

0:00 / 0:00

Published: March 2017, updated 2020

The Leopoldina uses cookies

We use cookies on our website. Some of them are necessary (functional cookies), while others are not necessary but help us to improve our online offering and operate it economically.

You can consent to the use of non-essential cookies by clicking on the "Accept all" button or by clicking on individual settings and agreeing to them by clicking on "Accept selection".

You can access these settings at any time and deselect cookies at a later date.

Functional

These cookies are technically necessary in order to provide the following core functionalities of the website:

  • Display of the website
  • Anonymisation of IP addresses within log files
  • Status cookie consent
Comfort

In addition to necessary cookies, we also use cookies to make your use of the website more pleasant. If you accept these cookies, external media will be loaded without your further consent.

Tracking

With the help of statistics cookies, we can better customise the content and services of our website to your interests and needs. For statistics and analyses, we use the product Matomo for statistics and analyses.

External link warning

Die Nutzung dieses Teildienstes erfordert ihre Einwilligung in die Verarbeitung zusätzlicher personenbezogener Daten durch einen selbständigen Verantwortlichen: Matterport Inc., 352 E. Java Drive, Sunnyvale, CA 94089, USA. Es gelten folgende Datenschutzhinweise: https://matterport.com/de/node/44. Mit der Einwilligung durch Klick auf „Ok“ kann auch eine Übermittlung von personenbezogenen Daten in ein Land außerhalb der Europäischen Union erfolgen. Die Einwilligung ist freiwillig. Eine Ablehnung führt zu keinen Nachteilen. Eine erteilte Einwilligung kann jederzeit mit Wirkung für die Zukunft widerrufen werden.

Ich bin damit einverstanden, dass bei Nutzung dieses Teildienstes zusätzliche personenbezogene Daten verarbeitet werden. Dabei verarbeitete Datenkategorien: technische Verbindungsdaten des Serverzugriffs (IP-Adresse, Datum, Uhrzeit, abgefragte Seite, Browser-Informationen), Daten zur Erstellung von Nutzungsstatistiken und Daten über die Nutzung der Website sowie die Protokollierung von Klicks auf einzelne Elemente. Zweck der Verarbeitung: Auslieferung von Inhalten, die von Dritten bereitgestellt werden. Rechtsgrundlage für die Verarbeitung: Ihre Einwilligung nach Art. 6 (1) a DSGVO, Art. 49 DSGVO. Verantwortlicher für die Datenverarbeitung Matterport Inc., 352 E. Java Drive, Sunnyvale, CA 94089, USA. Es gilt die Datenschutzerklärung von Matterport Inc.: https://matterport.com/de/node/44.

Visit page ▸